New drug alternatives

A TIENTS who do not respond to
AZT -the primary AIDS therapeutic drug produced and patented almo
worldwide by Burroughs Wellcome
Co -now have hope.

Studies at the US Nationi
Institutes of Health at Bethesd
Maryland, show two other drugs .
le DDC produced by Hoffmann
at Roche Inc and DDI, by Bristol-Meye
Squibb Co -are "similarly effectively in slowing the progress of AIDS
patients not responding to AZT .

DDI is already officially approved
for use by people whose condition
is worsens on taking AZT, but only as a
supporting drug along with AZT.
re Researchers, however, caution DDC
be can result in painful nerve damage to
arms and legs and Dm can cause
stomach upsets and pancreatitis.